Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients

Jiayi WU; Weiqi GAO; Xiaosong CHEN; Chunxiao FEI; Lin LIN; Weiguo CHEN; Ou HUANG; Siji ZHU; Jianrong HE; Yafen LI; Li ZHU; Kunwei SHEN

Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients / 医学前沿

Jiayi WU; Weiqi GAO; Xiaosong CHEN; Chunxiao FEI; Lin LIN; Weiguo CHEN; Ou HUANG; Siji ZHU; Jianrong HE; Yafen LI; Li ZHU; Kunwei SHEN.

Frontiers of Medicine ; (4): 621-628, 2021.

Article in En | WPRIM | ID: wpr-888733

Responsible library: WPRO

ABSTRACT

ABSTRACT

Multi-gene assays have emerged as crucial tools for risk stratification in early-stage breast cancer. This study aimed to evaluate the prognostic significance of the 21-gene recurrence score (RS) in Chinese patients with pN0-1, estrogen receptor-positive (ER

Subject(s)

Female; Humans; Biomarkers, Tumor/genetics; Breast Neoplasms/pathology; Neoplasm Recurrence, Local/pathology; Neoplasm Staging; Prognosis; Receptor, ErbB-2/genetics; Receptors, Estrogen

Key words

21-gene assay; early breast cancer; prognosis; recurrence score

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: WPRIM Main subject: Prognosis / Breast Neoplasms / Receptors, Estrogen / Biomarkers, Tumor / Receptor, ErbB-2 / Neoplasm Recurrence, Local / Neoplasm Staging Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Frontiers of Medicine Year: 2021 Type: Article

Fulltext

Add to My VHL

XML

Search on Google